Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine

被引:20
|
作者
von Hunolstein, C [1 ]
Teloni, R [1 ]
Mariotti, S [1 ]
Recchia, S [1 ]
Orefici, G [1 ]
Nisini, R [1 ]
机构
[1] Ist Super Sanita, Batteriol & Micol Med Lab, I-00161 Rome, Italy
关键词
Hib conjugate vaccine; immunostimulatory sequences; polysaccharide; type 1 immune response;
D O I
10.1093/intimm/12.3.295
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Synthetic oligodeoxynucleotides containing CpG motifs [immunostimulatory sequences (ISS)] have been described as potent adjuvants of type 1 immune responses when co-administered with protein or peptide vaccines. To investigate their role in the immune response to polysaccharides (CHO), different preparations of anti-Haemophilus influenzae type b (Hib) conjugate vaccine were administered to mice. The unconjugated CHO did not induce the synthesis of specific antibodies even in the presence of ISS. On the other hand, anti-CHO-specific antibodies significantly increased in the presence of ISS, when tetanus (TT) or diphtheria [cross-reacting material (CRM)] toxoid-conjugated CHO were used to immunize mice. The adjuvant effect was also observed for the immune response against the carrier protein (TT and CRM), ISS insured an early and long-lasting specific IgG production. The effects of ISS on the anti-CHO immune response could be attributed to the amplification of the T help provided by the carrier. The analysis of anti-CHO IgG subclasses showed a significant increase of IgG2a and IgG3 in the presence of ISS, ISS caused a rapid release of IL-12 and IFN-gamma in sera from treated mice. This data provide a first evidence for the ability of ISS to induce an anti-CHO type 1-like immune response and demonstrate that ISS have the potential to increase host antibody response against both the CHO and the protein component of a conjugated vaccine.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 50 条
  • [1] The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines
    von Hunolstein, C
    Mariotti, S
    Teloni, R
    Alfarone, G
    Romagnoli, G
    Orefici, G
    Nisini, R
    VACCINE, 2001, 19 (23-24) : 3058 - 3066
  • [2] A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b
    Verez-Bencomo, V
    Fernández-Santana, V
    Hardy, E
    Toledo, ME
    Rodríguez, MC
    Heynngnezz, L
    Rodriguez, A
    Baly, A
    Herrera, L
    Izquierdo, M
    Villar, A
    Valdés, Y
    Cosme, K
    Deler, ML
    Montane, M
    Garcia, E
    Ramos, A
    Aguilar, A
    Medina, E
    Toraño, G
    Sosa, I
    Hernandez, I
    Martínez, R
    Muzachio, A
    Carmenates, A
    Costa, L
    Cardoso, F
    Campa, C
    Diaz, M
    Roy, R
    SCIENCE, 2004, 305 (5683) : 522 - 525
  • [3] Immune response to Haemophilus influenzae type b conjugate vaccine in preterm infants
    Tsuda, Kennosuke
    Iwasaki, Shiho
    Horiguchi, Haruko
    Mori, Masaaki
    Nishimaki, Shigeru
    Seki, Kazuo
    Taguri, Masataka
    Yokota, Shumpei
    Ishiwada, Naruhiko
    PEDIATRICS INTERNATIONAL, 2012, 54 (01) : 64 - 67
  • [4] Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in the Gambia
    Mulholland, K
    Suara, RO
    Siber, G
    Roberton, D
    Jaffar, S
    NJie, J
    Baden, L
    Thompson, C
    Anwaruddin, R
    Dinan, L
    Glezen, WP
    Francis, N
    Fritzell, B
    Greenwood, BM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (15): : 1182 - 1188
  • [5] Incidence of Haemophilus influenzae Type b Disease in The Gambia 14 Years after Introduction of Routine Haemophilus influenzae Type b Conjugate Vaccine Immunization
    Oluwalana, Claire
    Howie, Stephen R. C.
    Secka, Ousman
    Ideh, Readon C.
    Ebruke, Bernard
    Sambou, Sana
    Erskine, James
    Lowe, Yamundow
    Corrah, Tumani
    Adegbola, Richard A.
    JOURNAL OF PEDIATRICS, 2013, 163 (01): : S4 - S7
  • [6] HAEMOPHILUS-INFLUENZAE TYPE-B EPIGLOTTITIS AFTER IMMUNIZATION WITH HBOC CONJUGATE VACCINE
    KEYSER, JS
    DERKAY, CS
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1994, 15 (06) : 436 - 443
  • [7] ANTIBODY-RESPONSE TO IMMUNIZATION WITH HAEMOPHILUS-INFLUENZAE TYPE B POLYSACCHARIDE VACCINE IN CHILDREN WITH CANCER
    WEISMAN, SJ
    CATES, KL
    ALLEGRETTA, GJ
    QUINN, JJ
    ALTMAN, AJ
    JOURNAL OF PEDIATRICS, 1987, 111 (05): : 727 - 729
  • [8] NEONATAL IMMUNIZATION - RESPONSE TO HAEMOPHILUS-INFLUENZAE TYPE B-TETANUS TOXOID CONJUGATE VACCINE
    KURIKKA, S
    KAYHTY, H
    PELTOLA, H
    SAARINEN, L
    ESKOLA, J
    MAKELA, PH
    PEDIATRICS, 1995, 95 (06) : 815 - &
  • [9] COMPARATIVE IMMUNE-RESPONSES TO HAEMOPHILUS-INFLUENZAE TYPE-B POLYSACCHARIDE AND A POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE
    KIM, KS
    WONG, VK
    ADLER, R
    STEINBERG, EA
    PEDIATRICS, 1990, 85 (04) : 648 - 650
  • [10] ANTI-CAPSULAR POLYSACCHARIDE ANTIBODY CONCENTRATIONS IN SALIVA AFTER IMMUNIZATION WITH HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES
    KAUPPI, M
    ESKOLA, J
    KAYHTY, H
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (04) : 286 - 294